IA
PRCT icon

IFP Advisors’s Procept Biorobotics PRCT Stock Holding History

IFP Advisors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Buy
12,062
+1,287
+12% +$32.2K ﹤0.01% 1339
2026
Q1 		$269K Buy
10,775
+3,640
+51% +$103K 0.01% 1242
2025
Q4 		$224K Buy
7,135
+2,111
+42% +$70K 0.01% 1316
2025
Q3 		$179K Buy
5,024
+974
+24% +$44.5K ﹤0.01% 1340
2025
Q2 		$233K Buy
4,050
+737
+22% +$41.7K 0.01% 1194
2025
Q1 		$193K Buy
3,313
+2,591
+359% +$177K 0.01% 1193
2024
Q4 		$58.1K Buy
+722
New +$61.7K ﹤0.01% 1758

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

IFP Advisors's PRCT Position: Q2 2026 in Review

IFP Advisors increased its Procept Biorobotics (PRCT) stake by 12% in Q2 2026, buying an estimated $32.2K and bringing the position to 12,062 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #1339.

IFP Advisors first reported a position in PRCT in Q4 2024 and has held it in 7 quarters since. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • IFP Advisors held 12,062 shares of Procept Biorobotics worth $272K as of Q2 2026.
  • IFP Advisors bought 1,287 Procept Biorobotics shares in Q2 2026, an estimated $32.2K.
  • Procept Biorobotics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #1339 holding.
  • IFP Advisors first reported a position in Procept Biorobotics in Q4 2024 and has held it in 7 quarters since.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.